rs12711538

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374353.1(GLI2):​c.3865G>A​(p.Asp1289Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.693 in 1,611,070 control chromosomes in the GnomAD database, including 391,822 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33527 hom., cov: 35)
Exomes 𝑓: 0.70 ( 358295 hom. )

Consequence

GLI2
NM_001374353.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.13

Publications

42 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.033025E-6).
BP6
Variant 2-120989830-G-A is Benign according to our data. Variant chr2-120989830-G-A is described in ClinVar as Benign. ClinVar VariationId is 95272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.724 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.3865G>A p.Asp1289Asn missense_variant Exon 14 of 14 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.3865G>A p.Asp1289Asn missense_variant Exon 14 of 14 1 NM_001374353.1 ENSP00000354586.5 A0A7I2PJA1

Frequencies

GnomAD3 genomes
AF:
0.659
AC:
100139
AN:
152032
Hom.:
33512
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.581
Gnomad AMI
AF:
0.802
Gnomad AMR
AF:
0.647
Gnomad ASJ
AF:
0.681
Gnomad EAS
AF:
0.477
Gnomad SAS
AF:
0.504
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.730
Gnomad OTH
AF:
0.668
GnomAD2 exomes
AF:
0.645
AC:
159215
AN:
246908
AF XY:
0.646
show subpopulations
Gnomad AFR exome
AF:
0.577
Gnomad AMR exome
AF:
0.580
Gnomad ASJ exome
AF:
0.671
Gnomad EAS exome
AF:
0.464
Gnomad FIN exome
AF:
0.676
Gnomad NFE exome
AF:
0.727
Gnomad OTH exome
AF:
0.671
GnomAD4 exome
AF:
0.697
AC:
1016406
AN:
1458920
Hom.:
358295
Cov.:
57
AF XY:
0.692
AC XY:
502381
AN XY:
725534
show subpopulations
African (AFR)
AF:
0.574
AC:
19197
AN:
33448
American (AMR)
AF:
0.585
AC:
26079
AN:
44578
Ashkenazi Jewish (ASJ)
AF:
0.677
AC:
17631
AN:
26046
East Asian (EAS)
AF:
0.474
AC:
18800
AN:
39656
South Asian (SAS)
AF:
0.526
AC:
45297
AN:
86064
European-Finnish (FIN)
AF:
0.673
AC:
35253
AN:
52356
Middle Eastern (MID)
AF:
0.636
AC:
3666
AN:
5768
European-Non Finnish (NFE)
AF:
0.729
AC:
809840
AN:
1110754
Other (OTH)
AF:
0.675
AC:
40643
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
18422
36845
55267
73690
92112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19880
39760
59640
79520
99400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.658
AC:
100174
AN:
152150
Hom.:
33527
Cov.:
35
AF XY:
0.652
AC XY:
48522
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.580
AC:
24099
AN:
41522
American (AMR)
AF:
0.646
AC:
9887
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.681
AC:
2363
AN:
3470
East Asian (EAS)
AF:
0.476
AC:
2459
AN:
5164
South Asian (SAS)
AF:
0.504
AC:
2431
AN:
4822
European-Finnish (FIN)
AF:
0.661
AC:
7004
AN:
10594
Middle Eastern (MID)
AF:
0.697
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
0.730
AC:
49583
AN:
67966
Other (OTH)
AF:
0.670
AC:
1412
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1789
3577
5366
7154
8943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.702
Hom.:
59648
Bravo
AF:
0.653
TwinsUK
AF:
0.718
AC:
2661
ALSPAC
AF:
0.723
AC:
2787
ESP6500AA
AF:
0.576
AC:
2536
ESP6500EA
AF:
0.728
AC:
6262
ExAC
AF:
0.644
AC:
78079
Asia WGS
AF:
0.499
AC:
1736
AN:
3478
EpiCase
AF:
0.735
EpiControl
AF:
0.735

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Holoprosencephaly 9 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.9
DANN
Benign
0.25
DEOGEN2
Benign
0.24
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0039
N
LIST_S2
Benign
0.24
.;T
MetaRNN
Benign
0.0000020
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.5
N;N
PhyloP100
2.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
1.9
N;N
REVEL
Benign
0.081
Sift
Benign
1.0
T;T
Sift4G
Benign
0.92
T;T
Polyphen
0.0
B;B
Vest4
0.011
MPC
0.32
ClinPred
0.00087
T
GERP RS
2.1
Varity_R
0.039
gMVP
0.047
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12711538; hg19: chr2-121747406; COSMIC: COSV58041761; COSMIC: COSV58041761; API